Home > Insider Trading > Charles River Laboratories International Inc.

Charles River Laboratories International Inc. (CRL)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

Charles River Laboratories International, Inc. (NYSE:CRL) Q4 2023 Earnings Call Transcript

Charles River Laboratories International, Inc. beats earnings expectations. Reported EPS is $2.46, expectations were $2.39. Charles River Laboratories International, Inc.

Keep Reading →

February 15th, 2024 - News Transcripts

10 Narrow Moat Stocks Hedge Funds Are Buying

Investors who are new to the stock market often get confused by the term moat. This is because moat is not easily defined and cannot be quantified based on numbers alone.

Keep Reading →

January 12th, 2024 - Hedge Funds News

Charles River Laboratories International, Inc. (NYSE:CRL) Q3 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Charles River Laboratories' Third Quarter 2023 Earnings Conference Call. This call is being recorded.

Keep Reading →

November 10th, 2023 - News Transcripts

Long-Term Returns of Billionaire Barry Rosenstein's Activist Targets

In this article, we discuss the long-term returns of Rosenstein's Jana Partners' activist targets.

Keep Reading →

September 12th, 2023 - Activism Hedge Funds News

Charles River Laboratories International, Inc. (NYSE:CRL) Q2 2023 Earnings Call Transcript

Operator: Please stand by your program is about to begin.

Keep Reading →

August 12th, 2023 - News Transcripts

Charles River Laboratories International, Inc. (NYSE:CRL) Q1 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Charles River Laboratories First Quarter 2023 Earnings Conference Call. This call is being recorded.

Keep Reading →

May 12th, 2023 - News Transcripts

Hedge Fund and Insider Trading News: Marc Lasry, Standard General, Third Point LLC, Irenic Capital Management, Millennium Management, Soroban Capital Partners, Point72 Asset Management, Vishay Precision Group Inc (VPG), Spruce Biosciences Inc (SPRB), and More

Billionaire investor Marc Lasry has reached a deal to sell his stake in the Milwaukee Bucks to Jimmy and Dee Haslam, owners of the National Football League’s Cleveland Browns, according to a person ...

Keep Reading →

February 27th, 2023 - Hedge Funds Insider Trading

Charles River Laboratories International, Inc. (NYSE:CRL) Q4 2022 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Charles River Laboratories Fourth Quarter and Full Year 2022 Earnings Conference Call. This call is being recorded.

Keep Reading →

February 23rd, 2023 - News Transcripts

Should You Invest in Charles River Laboratories International (CRL) for the Long-Term?

Jackson Square Partners, an investment management firm, released its “SMID-Cap Growth” Q3 2022 investor letter. A copy of the same can be downloaded here.

Keep Reading →

December 22nd, 2022 - Hedge Fund Investor Letters News